期刊文献+

自行研制小儿胸腔镜心脏手术插管的细胞毒性研究 被引量:2

Cytotoxidty of modified PVC materials used in thoracoscopic pediatric cardiac surgery cannulae
原文传递
导出
摘要 目的评价自行研制小儿胸腔镜心脏手术各种动、静脉插管的细胞毒性。方法对插管材料进行体外细胞培养,通过琼脂覆盖实验及噻唑蓝(MTT)实验观察细胞存活情况及活性,并与进口同类产品相对照。结果琼脂覆盖实验结果显示细胞溶解率小于20%,与对照组之间差异无统计学意义;噻唑蓝(MTT)结果显示50%材料浸提液1、3、5、7 d的细胞相对增殖率分别为85%、83%、81%及78%,具有轻微的细胞毒性。结论自行研制插管材料具有良好的生物相容性,细胞毒性轻微,可进一步应用于临床。 To evaluate the cytotoxicity of the PVC materials used in the modified cannulae in thoracoscopic assisted pediatric cardiac surgery. Methods Through in vitro cell culture, agar overlay test and MTT assay, cytotoxicity and cell activity of the self-developed PVC materials were evaluated and compared with controls. Results Agar overlay test showed that the cytolysis rate of the self-devel- oped PVC materials was lower than 20% , and there was no statistical difference with control group. MTT assay results revealed that the relative growth rate (RGR) of 50% leaching liquid after 1,3,5 and 7 days was 85% , 83% , 81% and 78% respectively. The self-developed PVC materials had slight cytotoxicity as compared with Medtronic DLP cannulae. Conclusion The PVC materials used in the modified arterial cannulae in thoracoscopic assisted pediatric cardiac surgery have little cytotoxicity and good biocompatibility. The newly designed cannulae set can be further applied to clinical use.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2007年第10期1246-1247,共2页 Chinese Journal of Experimental Surgery
基金 国家"十五"科技攻关计划资助项目(2004BA720A12)
关键词 胸腔镜 心脏手术 细胞毒性 材料 Thoracoscopy Heart surgery Cytotoxicity Material
  • 相关文献

参考文献8

二级参考文献30

  • 1史嘉玮,孙宗全.冠心病血运重建术与趋化性细胞因子的研究进展[J].中华实验外科杂志,2004,21(11):1405-1406. 被引量:4
  • 2[1]Nakamoto H,Suzuki T,Sugahara S,et al.Successful use of thoracoscopic pericardiectomy in elderly patients with massive pericardial effusion caused uremic pericarditis[J].A m J Kidney Dis,2001; 37(6):1294-1298.
  • 3[2]Schoreyers P,Wellens F,De Geest R,et al.Minimally invasive video-assisted mitral valve repair short and midterm results[J].J Heart Valve Dis,2001 ;10(5):579-583.
  • 4[3]Le Bret E,Folliquet TA,Cborde F.Vidothoracoscopic surgical interrupt of patent ductus arteriosus[J].Ann Thorac Surg,1997 ;64(5):1492-1494.
  • 5[4]Ishikawa M,Nagase M,Kachi H,et al.A case of an 86 year old patient treated with thoracoscopic percardiectomy of recurrent pericardial fusion[J].Kyobu Geka,1999; 52 (3):225 -228.
  • 6[5]Burke RP,Jacobs J P,Cheng W,et al.Video-assisted thoracoscopic surgery for patent ductus arteriosus in low birth weight neonates and infants[J].Pediat rics,1999; 104 (2 pt1):227-230.
  • 7[6]Lin PL,Chang CH,Chu JJ,et al.Video -essisted coronary artery bypass grafting during hypothermic fibrillatory arrest[J].Ann Thorac Surg,1997;63(2):1113-1117.
  • 8[7]Lei KB,Luo WJ,Zhang WX,et al.Report of video-assisted thoracoscopic operation on heart for six cases[J].Zhongguo Neijing Zazhi (Chin J Endosc),2000;6(3):51-53.
  • 9[9]Chang CH,Lin PJ,Liu HP,et al.Video-assisted cardiac surgery in closure of atrial septal defect[J].J Thorac Cardiovasc Surg,1996;62(3):697-701.
  • 10[11]Hu DY,Chen L,Tang YH,et al.Breathing support of high frequency jet ventilation after cardiopulmonary bypass[J].Zhonghua Xiongxin Xueguan Waike Zazhi (Chin J Thorac Cardiovasc Surg),1997; 13 (3):169-170.

共引文献85

同被引文献17

  • 1Jorge HE, Fernandez P, Tumay J, et al. Influence of different chemical crosslinking treatments on the properties of porcine aortic valve and collagen. Biomaterials, 1999,20:539-545.
  • 2Nugent HM, Edelman ER. Tissue engineering therapy for cardiovascu- lar disease. Circ Res,2003,92 : 1068-1078.
  • 3Chang Y, Hsu CK, We HJ, et al. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin : In vitro and in vivo studies. J Biotechno1,2005,120:207-219.
  • 4Moore MA, Adams AK. Calcification resistance, biostability and low immunogenic potential of porcine heart valves modified by dye-media- ted photooxidation. J Biomed Mater Res ,2001,56:24-30.
  • 5Moore MA, Bohachevsky IK, Cheung DT, et al. Stabilization of peri- cardial tissue by dye-mediated photooxidation. J Biomed Mater Res, 1994,28:611-618.
  • 6Liu Yang, Liu WY, Yi DH, et al. Calcification resistance with proeya- nidins treated deeellularized porcine aortic valve in vivo. Heart Surg Forum,2009,12:24-29.
  • 7Mulinari LA, Navarro FB, Pimentel GK, et al. The use and midium- term evaluation of decellularized allograft cusp in the surgical treat- ment of the tetralogy of fallot. Rev Bras Cir Cardiovasc ,2008,23 : 197- 203.
  • 8Bechtel JF, Muller-Steinhardt M, Schmidtke C, et al. Evaluation of the decellularized pulmonary valve homograft ( SynerGraft). J Heart Valve Dis ,2003,12:734-739.
  • 9Simon P, Kasimir MT, Seehacher G, et al. Ear/y failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorae Surg,2003,23 : 1002-1006.
  • 10Zhai W, Chang J, Lin K, et al. Crosslinking of decellularized porcine heart valve matrix by procyanidins. Biomaterials, 2006, 27:3684- 3690.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部